What’s Going On With Novo Nordisk Stock Thursday? – Novo Nordisk (NYSE:NVO)
Oral Semaglutide Shows Superior Glycaemic Control The phase 3a study evaluated oral semaglutide in patients aged 10–17 years…
Novo Nordisk Extends Lead As Eli Lilly New Obesity Pill Sees Modest Launch Uptake – Eli Lilly (NYSE:LLY)
Early Prescription Trends Show Slower Start For Lilly Reuters, citing IQVIA data, reported that Eli Lilly recorded 1,390…
Novo Nordisk Sued Over Alleged Scheme To Delay Generic Victoza In Favor Of Ozempic – Novo Nordisk (NYSE:NVO)
Novo Nordisk A/S (NYSE:NVO) is accused of unlawfully extending its monopoly over its diabetes drug Victoza through a…
Jeff Bezos Space Internet Ambitions Falter As Amazon’s Project Kuiper Struggles To Increase Satellite Production Amid Launch Delays – Amazon.com (NASDAQ:AMZN), Boeing (NYSE:BA)
Amazon.com Inc.’s AMZN Project Kuiper, a space-based internet company is struggling to scale its low Earth orbit satellite…
Rezolute ‘Thrilled’ With Positive Review Of Genetic Disorder Trial, Expects Topline Results In December – Rezolute (NASDAQ:RZLT)
Rezolute, Inc. RZLT on Wednesday announced the Independent Data Monitoring Committee’s (DMC) recommendation to continue the Phase 3 sunRIZE…